Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical Trial
Author(s) -
Jane R. Schwebke,
Anne Rompalo,
Stephanie N. Taylor,
Arlene C. Seña,
David H. Martin,
Laureen M Lopez,
Shelly Lensing,
J. Y. Lee
Publication year - 2010
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciq074
Subject(s) - azithromycin , urethritis , medicine , doxycycline , tinidazole , mycoplasma genitalium , chlamydia trachomatis , regimen , randomized controlled trial , chlamydia , trichomonas vaginalis , surgery , gastroenterology , gynecology , antibiotics , metronidazole , immunology , microbiology and biotechnology , biology
Nongonococcal urethritis (NGU) is a common chlamydia-associated syndrome in men; however, Trichomonas vaginalis and Mycoplasma genitalium are associated with its etiology and should be considered in approaches to therapy. We sought to determine whether the addition of tinidazole, an anti-trichomonal agent, to the treatment regimen would result in higher cure rates than those achieved with treatment with doxycycline or azithromycin alone. A secondary aim was to compare the efficacy of doxycycline therapy and with that of azithromycin therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom